A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence
This study has been completed.
Sponsor:
Alza Corporation, DE, USA
Information provided by:
Alza Corporation, DE, USA
ClinicalTrials.gov Identifier:
NCT00269724
First received: December 22, 2005
Last updated: May 18, 2011
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | September 1997 |
| Estimated Primary Completion Date: | No date given |